NCT06351228

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project

Name: Clinical Trial NCT06351228
Creator: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Keywords: Cervical Cancer, Conization plus nodal evaluation, other, clinical trial, Italy

Outcomes of Early-stage Cervcial Cancer Patients Sheduled to Have Fertility-sparing Approach: The ETERNITY Project

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Cervical Cancer
Drug/Device/Intervention: Conization plus nodal evaluation
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Location: Milano, Italy

Timeline & enrollment

Phase: N/A
Start date: Mar 30, 2024
End date: Dec 31, 2024
Enrollment: 400 participants

Primary outcome

oncological outcomes

Summary

The ETERNITY project is a retrospective analysis of outcomes of patients undergoing fertility-sparing treatment for cervcial cancer.  The primary aim is to report outcomes of those patients.  Other aims included:  1. Evaluation about the effectiveness of different treatment modalities;  2. Evaluation of outcomes according to different stages of disease;  3. Evaluation of the impactof neoadjuvant chemotherapy in patients undergoing conservative surgery

ICD-10 classifications

Severe cervical dysplasia, not elsewhere classifiedMild cervical dysplasiaModerate cervical dysplasiaCarcinoma in situ: Cervix, unspecifiedCervical root disorders, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06351228
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06351228 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano and is currently Not yet recruiting. The study focuses on Cervical Cancer. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.